How EU FMD Continues to Shape Pharmaceutical Packaging Standards
2026-08-12

Since its full implementation, the EU Falsified Medicines Directive (FMD) 2011/62/EU has fundamentally transformed pharmaceutical packaging requirements across Europe. The directive mandates safety features including unique identifiers and anti-tampering devices on prescription medicine packaging.\n\nFor packaging material suppliers like Green Medical Packing, the FMD has driven increased demand for high-quality PVC sheets that can accommodate serialization printing, QR codes, and data matrix codes without compromising seal integrity or visual clarity. Our standard blister PVC sheets are specifically engineered with optimized surface properties for high-resolution inkjet and thermal transfer printing.\n\nThe FMD has also elevated the importance of supply chain traceability, requiring packaging materials to meet consistent quality standards across all production batches. Our ISO 15338 certified quality management system ensures batch-to-batch consistency that pharmaceutical manufacturers rely on for regulatory compliance.
Have questions about this topic?
Send your pack format and target market — our technical team replies within 48 hours.
Recommended materials
Materials referenced in this article

APET Rigid Film
High-clarity amorphous PET rigid film for thermoformed pharmaceutical and medical packaging
View specifications
PVC/APET Laminated Rigid Sheet
Composite PVC/APET rigid sheet combining forming performance with a high-gloss print surface
View specifications
Standard Blister PVC
Versatile PVC sheets for thermoformed blister packaging
View specifications

